key: cord-0692182-jx775vus
authors: Yalçinkaya, Rumeysa; Polat, Meltem; Gümüşer Cinni, Rüveyda; Öz, Fatma Nur; Tanir, Gönül; Uysal Yazici, Mutlu
title: Crimean-Congo Hemorrhagic Fever Mimicking Multisystem Inflammatory Syndrome in Children Associated With COVID-19: A Diagnostic Challenge
date: 2021-07-20
journal: Pediatr Infect Dis J
DOI: 10.1097/inf.0000000000003269
sha: 3a59ebfb2503185ce9d36113c65deba9ba217c64
doc_id: 692182
cord_uid: jx775vus

nan

The First Report of Sphingomonas yanoikuyae as a Human Pathogen in a Child With a Central Nervous System Infection To The Editors:

S phingomonas spp. are aerobic, yellowpigmented, glucose nonfermenting, Gram-negative bacterium and a rare cause of human infections. 1 Herein, we report a case of Sphingomonas yanoikuyae central nervous system infection in a child. This is the first report of S. yanoikuyae as a human pathogen to the best of our knowledge.

A 31-month-old male with a history of type 3 von Willebrand disease, decompressive craniectomy due to intracranial hemorrhage and tracheostomy was admitted to the hospital with fever and swelling in the skin flap area. The computed tomography revealed hydrocephalus, and a shunt operation was planned via neurosurgery. Before surgery, magnetic resonance imaging was performed and revealed a collection compatible with subdural empyema with an approximate diameter of 3.5 cm. Therefore, abscess drainage and external ventricular drain placement were performed. Cerebral spinal fluid (CSF), blood and abscess cultures were negative. On the 58th day of hospitalization, he had a fever, and S. yanoikuyae was isolated from the CSF culture. It was sensitive to meropenem, tobramycin and amikacin. Treatment was switched to meropenem. However, his CSF cultures grew recurrent S. yanoikuyae, and intrathecal amikacin was added to his treatment. After 14 days of meropenem and 5 days of intrathecal amikacin treatment, his CSF culture became sterile. Total meropenem therapy was discontinued after 28 days.

In our case, all the cultures, identification and antimicrobial susceptibility tests were done according to European Committee on Antimicrobial Susceptibility Testing criteria. The CSF samples were inoculated into the VersaTREK blood culture bottles (TREK Diagnostic Systems, Cleveland, OH). The bottles became positive within 24 hours of initial incubation. On Gram-stained smears from the culture-positive bottles, the organisms appeared as Gram-negative bacteria. Yellow-pigmented colonies were seen after an overnight blood agar medium subculture from positive blood bottles. The identification of bacteria was done by conventional methods and VITEK MS (bioMérieux, France). Vitek-MS is using matrixassisted laser desorption ionization-time of flight mass spectrometry technology for species identification based on the protein composition of microbial cells. Kirby Bauer disc diffusion method and VITEK 2 automated system (bioMérieux) were used to determine antibiotic susceptibility.

Sphingomonas spp. are commonly observed in the natural environment and rarely in hospitals. [2] [3] [4] The organism can be found in medical devices, contaminated fluid and respirators in the hospital. 4 It can cause infections as pneumonia, intravascular catheter-related infections, skin and soft tissue infections, urinary tract infections and meningitis. [1] [2] [3] [4] Little is known about the S. yanoikuyae susceptibility pattern. In one study, the antimicrobial susceptibilities of 86 different strains of Sphingomonadaceae were tested, and colistin resistance was observed to be intrinsic. 5 Bayram et al 3 reported that the most effective antibiotics to Sphingomonas paucimobilis infections were fluoroquinolones, carbapenems, trimethoprim/sulfamethoxazole, and the most resistant pattern identified against third generation cephalosporins.

In conclusion, our case is the first report of S. yanoikuyae as a human pathogen. Due to this specimen's limited antimicrobial susceptibility data, it is challenging for clinicians to treat this rare bacteria. We recommend raising awareness of this rare organism associated with nosocomial infection, especially in patients with indwelling intravascular devices. C rimean-Congo hemorrhagic fever (CCHF), which is endemic in our country, is a zoonotic disease characterized by fever and hemorrhage that may be severe and even fatal. The primary transmission route to humans is tick bite; however, other forms of transmission are also reported including direct contact with blood or other bodily fluids of infected animals, nosocomial and vertical transmission. 1 The clinical diagnosis of CCHF is difficult to establish because symptoms are nonspecific in the prehemorrhagic phase of the disease and laboratory findings are similar to other childhood infectious diseases. 1,2 Here, we report two cases with fever, elevated inflammatory markers, and multisystem organ involvement initially considered as multisystem inflammatory syndrome in children (MIS-C), but subsequently diagnosed with CCHF-highlighting the diagnostic challenge in distinguishing MIS-C from other infectious diseases. To our knowledge, no CCHF cases misdiagnosed as MIS-C have been reported to date.

A 9-year-old boy was referred to our clinic with a preliminary diagnosis of MIS-C because of persisting fever, abdominal pain, conjunctivitis and increasing levels of acute phase reactants despite intravenous antibiotic treatment. His mother had been diagnosed with coronavirus disease-2019 (COVID-19) 2 months prior to admission. On admission, he had tachycardia (130 beats/min), conjunctivitis and maculopapular rash. His laboratory examination revealed lymphocytopenia, thrombocytopenia and elevated levels of liver function tests, troponin, pro-brain natriuretic peptide (pro-BNP) and inflammatory markers including procalcitonin (Table 1) . Although all MIS-C criteria were met, CCHF diagnosis was also suspected, despite lack of tick bite, since the patient had progressively decreasing platelet count, and had a history of living in an endemic area and his family was engaged in animal husbandry. Polymerase chain reaction (PCR) test for CCHF was positive, and the patient was treated and discharged without any complications.

A 15-year-old boy was referred to our hospital with a preliminary diagnosis of MIS-C because of having fever, conjunctivitis, gastrointestinal symptoms, elevated inflammatory markers and history of exposure to his father who had documented COVID-19 infection three months ago. On admission, he had fever, bilateral conjunctivitis, and malar rash. Laboratory analysis revealed lymphocytopenia and thrombocytopenia in addition to elevated inflammatory markers (Table 1) . Detailed questioning revealed that he had a history of close contact with animals; however, history of tick bite was not present. On the following days, his fever persisted and platelet count continued to decrease. CCHF PCR was positive and he was treated successfully.

To conclude, similar to MIS-C, clinical manifestations of CCHF include fever, headache, myalgia, rash, conjunctivitis, abdominal pain, nausea, vomiting and diarrhea. 1, 3 Detailed patient history and differential diagnosis are important to avoid unnecessary treatment and protect healthcare providers since infection control measures are essential in CCHF. Our two cases highlight that CCHF should be ruled out when evaluating possible MIS-C, even in the absence of tick bite history, especially in patients with progressive decline in platelet count, those living in endemic areas, and those with a history of close contact with animals.

Proposals of Sphingomonas paucimobilis gen. nov. and comb. nov., Sphingomonas parapaucimobilis sp

Sphingomonas paucimobilis bacteremia in humans: 16 case reports and a literature review

Sphingomonas paucimobilis infections in children: 24 case reports

Sphingomonas paucimobilis: an unusual cause of meningitis-case report

Diversity and antibiotic resistance patterns of Sphingomonadaceae isolates from drinking water

Diagnosis of Crimean-Congo hemorrhagic fever

Various clinical conditions can mimic Crimean-Congo hemorrhagic fever in pediatric patients in endemic regions

Multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 (COVID-19)

Ribavirin Ribavirin ALT indicates alanine aminotransferase; AST, aspartate aminotransferase; BNP, brain natriuretic peptide; CCHF, Crimean-Congo hemorrhagic fever; COVID-19, coronavirus disease 19; CRP, C-reactive protein; LDH, lactate dehydrogenase; MIS-C, multisystem inflammatory syndrome; RT-PCR, reverse transcriptase polymerase chain reaction; SARS-CoV-2, severe acute respiratory system coronavirus 2.